SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244346
Filing Date
2018-08-09
Accepted
2018-08-09 16:17:17
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d921331d10q.htm 10-Q 570217
2 EX-10.29 d921331dex1029.htm EX-10.29 3593
3 EX-31.1 d921331dex311.htm EX-31.1 11161
4 EX-31.2 d921331dex312.htm EX-31.2 11114
5 EX-32.1 d921331dex321.htm EX-32.1 5885
12 GRAPHIC g921331g29s66.jpg GRAPHIC 151112
  Complete submission text file 0001193125-18-244346.txt   2938197

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20180630.xml EX-101.INS 428519
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20180630.xsd EX-101.SCH 32569
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20180630_cal.xml EX-101.CAL 39832
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20180630_def.xml EX-101.DEF 111270
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20180630_lab.xml EX-101.LAB 277167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20180630_pre.xml EX-101.PRE 188101
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 181005261
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences